Healthcare - Biotechnology - NASDAQ - US
$ 0.2593
-5.74 %
$ 6.96 M
Market Cap
-0.08
P/E
Price Target
Average
4142.19%
Revenue Forecast
Estimate
--36.00%
EBIT
Estimate
66.28%
Net Income
Estimate
19.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Syros Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SYRS of $11 , with forecasts ranging from a low of $5 to a high of $15 .
SYRS Lowest Price Target
Wall Street Target
5 USD
1828.27%
SYRS Average Price Target
Wall Street Target
11 USD
4142.19%
SYRS Highest Price Target
Wall Street Target
15 USD
5684.81%
REVENUE FORECAST
Revenue Forecast Chart SYRS
EBIT FORECAST
EBIT Forecast Chart SYRS
NET INCOME FORECAST
Net Income Chart SYRS